1 / 3

Global Urothelial Cancer Treatment Market Growth, Size, Share and Industry Report to 2019-2025

The global urothelial cancer treatment market is estimated to witness significant growth during the forecast period.

nabeelomr
Download Presentation

Global Urothelial Cancer Treatment Market Growth, Size, Share and Industry Report to 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global urothelial cancer treatment market is estimated to witness significant growth during the forecast period. The rising frequency of urothelial cancer among middle-aged and older- aged people is driving the market. About 90% of the urothelial cancer patients are older than 55 years and the average age of people are diagnosed with urothelial cancer is 73 years. Due to the growing incidence of urothelial cancer, drug manufacturers are making efforts to develop innovative cancer therapies. Immunotherapy has less toxicity than chemotherapy which makes it more suitable for the elderly population. Immunotherapy shows a rapid and sustained response as compared to chemotherapy. The companies present in the market are focused on developing innovative diagnostic and treatment solutions for urothelial cancer. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/urothelial-cancer- treatment-market Immunotherapy, also called biologic therapy. This therapy is intended to boost the natural immune system to fight cancer. Immunotherapy is of two types, local therapy, and systemic therapy. Bacillus Calmette-Guerin (BCG), a standard Immunotherapy drug, used for the treatment of urothelial cancer. Through the catheter, it is directly placed into the bladder. Interferon (Roferon-A, Intron A, Alferon), another type of Immunotherapy it is combined with BCG for the treatment of urothelial cancer. Some of the major drugs used in Immunotherapy are Atezolizumab (Tecentriq), Avelumab (Bavencio), Durvalumab (Imfinzi), Nivolumab (Opdivo), Pembrolizumab (Keytruda), and others. Browse for Full Report at: https://www.omrglobal.com/industry-reports/urothelial-cancer- treatment-market The companies present in the market are focused on developing innovative treatment solutions for urothelial cancer treatment. For instance, in May 2016, the company got FDA approval for its cancer immunotherapy Tecentriq (atezolizumab) for the treatment of a specific type of advanced bladder cancer. Further, in 2017, the FDA granted approval to nivolumab (Opdivo) for the treatment of bladder cancer. This makes nivolumab one of the immune checkpoint inhibitor among 5 inhibitors approved for the treatment of bladder cancer. Such advancement is

  2. expected to boost the growth of the global urothelial cancer treatment market in the near future. Global Urothelial Cancer Treatment Market Segmentation By Therapy Type Chemotherapy Immunotherapy Others ( Targeted Therapy & Radiation Therapy) Global Global Urothelial Cancer Treatment Market– Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India

  3. •Rest of Asia-Pacific Rest of the World For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/urothelial-cancer-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related